Molecular Medicine is the international, peer-reviewed, biomedical journal published by the Feinstein Institute for Medical Research (New York). Molecular Medicine strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. Manuscripts submitted to the journal should maintain this focus and describe the implications for human disease, at a level approachable by the broad readership of Molecular Medicine. The 2011 Journal Citation Report (JCR), showing impact factors calculated from citations of articles published in 2010 and 2009, lists Molecular Medicine with an impact factor of 3.757. JCR category rankings are as follows: Medicine, Research & Experimental 24/111, Cell Biology 72/180, Biochemistry & Molecular Biology 91/289. Molecular Medicine publishes work in the format of original research articles, review articles, editorials, commentaries and letters to the editor covering emerging concepts in the interdisciplinary field of molecular medicine.Molecular Medicine places high priority on rapid publication. All content is published free online, ahead of print, within an average of 8 days after acceptance on our Web site www.molmed.org. Following acceptance, papers are posted rapidly to PubMed, with an e-publication ahead of print citation. Molecular Medicine is an open access journal and does not embargo content.
Molecular Neurodegeneration is ready to receive manuscripts on all aspects of neurodegeneration research at the molecular and cellular levels.
molecular therapy, gene therapy, cell-based therapy, technology development, drug development
animal behaviour, biogeography, environmental sciences, evolutionary biology, mathematical ecology, organism movement
Neural Development welcomes manuscripts on all aspects of research that use molecular, cellular, physiological or behavioral methods to provide novel insights into the mechanisms that underlie the formation of the nervous system.
NeuroCommons is dedicated to understanding how the brain functions, both in health and disease, and welcomes submissions from across the full breadth of the neurosciences. The journal provides a platform for researchers to share their basic research, experimental data, and related research outputs in an open and FAIR manner.
neurology, imaging
Nutrition Journal is ready to receive manuscripts on all aspects of human and clinical nutrition, as well as research articles in the field of nutrition.
Nutrition & Metabolism is ready to receive manuscripts on all aspects of nutritional biochemistry and related clinical fields.
One Health Outlook is published in collaboration with the One Health Platform. A strategic forum of stakeholders and a One Health reference network that aims to enhance understanding of and preparedness for the current and future outbreaks of zoonoses, emerging infectious diseases in humans and animals, and antimicrobial resistance, including the ecological and environmental factors which impact on these diseases.
The official journal of Orphanet, the European portal for rare diseases and orphan drugs Orphanet Journal of Rare Diseases is an open access, online journal that encompasses all aspects of rare diseases and orphan drugs. The journal publishes high quality reviews solicited from experts in the field and also considers research on new syndromes and results of clinical trials of exceptional interest.
Parasites & Vectors is an open access, peer-reviewed online journal dealing with the biology of parasites, parasitic diseases, intermediate hosts, vectors and vector-borne pathogens. Manuscripts published in this journal will be available to all worldwide, with no barriers to access, immediately following acceptance. However, authors retain the copyright of their material and may use it, or distribute it, as they wish.
Manuscripts on all aspects of the basic and applied biology of parasites, intermediate hosts, vectors and vector-borne pathogens will be considered. In addition to the traditional and well-established areas of science in these fields, we also aim to provide a vehicle for publication of the rapidly developing resources and technology in parasite, intermediate host and vector genomics and their impacts on biological research. We are able to publish large datasets and extensive results, frequently associated with genomic and post-genomic technologies, which are not readily accommodated in traditional journals. Manuscripts addressing broader issues, for example economics, social sciences and global climate change in relation to parasites, vectors and disease control, are also welcomed.
The electronic format of the journal offers interesting opportunities for authors. For example, in addition to the publication of large datasets, derived from field and laboratory studies, there is no limit to the number of color illustrations that can be included. Animations, slide shows and movie clips are acceptable, as also are links to relevant material on other websites. No additional charge will be made for these.
Particle and Fibre Toxicology is interested in receiving manuscripts which report new scientific data, hypotheses and reviews on the toxicological effects of particles and fibres. The journal functions as a forum for scientific debate and communication between toxicology and disciplines that develop (nano)particles for future applications.
Patient Safety in Surgery encompasses all issues related to safety and quality of patient care in surgery and surgical subspecialties. The journal has published a number of Editorials discussing topical issues important to the development of this field.